This report provides a comprehensive overview of the AI in Pharmaceutical Market from 2024 to 2030, including financial status, advancements, and market scenario. It highlights the potential for AI to revolutionize drug discovery and healthcare, with applications ranging from drug design to post-market surveillance. The market is expected to reach USD 21.78 billion by 2030, with a CAGR of 21.4% during the forecast period.